99 related articles for article (PubMed ID: 1990597)
1. Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts.
Morris RE; Wang J
Transplant Proc; 1991 Feb; 23(1 Pt 1):493-6. PubMed ID: 1990597
[No Abstract] [Full Text] [Related]
2. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.
Morris RE; Wang J; Blum JR; Flavin T; Murphy MP; Almquist SJ; Chu N; Tam YL; Kaloostian M; Allison AC
Transplant Proc; 1991 Apr; 23(2 Suppl 2):19-25. PubMed ID: 2063417
[No Abstract] [Full Text] [Related]
3. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.
Morris RE; Hoyt EG; Murphy MP; Eugui EM; Allison AC
Transplant Proc; 1990 Aug; 22(4):1659-62. PubMed ID: 2389428
[No Abstract] [Full Text] [Related]
4. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
[No Abstract] [Full Text] [Related]
5. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.
Wang J; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655
[No Abstract] [Full Text] [Related]
6. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts.
Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A
Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905
[No Abstract] [Full Text] [Related]
7. Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
Tanabe M; Todo S; Murase N; Irish W; Miyazawa H; Fujisaki S; Starzl TE
Transplant Proc; 1995 Feb; 27(1):364-5. PubMed ID: 7533411
[No Abstract] [Full Text] [Related]
8. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785).
Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW
Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444
[No Abstract] [Full Text] [Related]
9. Synergistic effects of mycophenolate mofetil (MMF, RS-61443) and anti-LFA-1/ICAM-1 monoclonal antibodies on the prolongation of heart allograft survival in rats.
Takazawa K; Hosoda Y; Bashuda H; Seino K; Yagita H; Tamatani T; Miyasaka M; Okumura K
Transplant Proc; 1996 Jun; 28(3):1980-1. PubMed ID: 8658967
[No Abstract] [Full Text] [Related]
10. Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection.
D'Alessandro AM; Rankin MA
Transplant Proc; 1994 Jun; 26(3):1611-2. PubMed ID: 8030056
[No Abstract] [Full Text] [Related]
11. Low-dose combination therapy of DUP-785 and RS-61443 prolongs cardiac allograft survival in rats.
Bechstein WO; Suzuki Y; Kawamura T; Jaffee B; Allison A; Hullett DA; Sollinger HW
Transpl Int; 1992; 5 Suppl 1():S482-3. PubMed ID: 14621853
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of canine intestinal allograft survival with RS-61443, cyclosporine, and prednisone.
D'Alessandro AM; Rankin M; McVey J; Hafez GR; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1993 Feb; 25(1 Pt 2):1207-9. PubMed ID: 8442088
[No Abstract] [Full Text] [Related]
14. Small bowel transplantation in rats using RS-61443: effect on GVHD and rejection.
Shaffer D; Blakely ML; Gottschalk R; Monaco AP
Transplant Proc; 1992 Jun; 24(3):1159-60. PubMed ID: 1604568
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of mycophenolate mofetil in heart transplant recipients.
Seebacher G; Mallinger R; Laufer G; Grimm M; Griesmacher A; Weigel G; Wolner E; Müller MM
Adv Exp Med Biol; 1998; 431():801-3. PubMed ID: 9598174
[No Abstract] [Full Text] [Related]
16. Tolerance induction in adult mice: cyclosporine inhibits RS-61443-induced tolerance.
Hao L; Calcinaro F; Lafferty KJ; Allison AC; Eugui EM
Transplant Proc; 1991 Feb; 23(1 Pt 1):733-4. PubMed ID: 1990669
[No Abstract] [Full Text] [Related]
17. Tolerance induction in adult animals: comparison of RS-61443 and anti-CD4 treatment.
Coulombe M; Hao L; Calcinaro F; Gill RG; Eugui EM; Allison AC; Lafferty KJ
Transplant Proc; 1991 Apr; 23(2 Suppl 2):31-2. PubMed ID: 2063419
[No Abstract] [Full Text] [Related]
18. Prolongation of dog renal allograft survival by RS-61443, a new, potent immunosuppressive agent.
Platz KP; Eckhoff DE; Hullett DA; Sollinger HW
Transplant Proc; 1991 Feb; 23(1 Pt 1):497-8. PubMed ID: 1990598
[No Abstract] [Full Text] [Related]
19. Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.
Klupp J; van Gelder T; Dambrin C; Regieli J; Boeke K; Billingham ME; Morris RE
Transplant Proc; 2001 May; 33(3):2170-1. PubMed ID: 11377490
[No Abstract] [Full Text] [Related]
20. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
